FGFBP2 Antikörper (AA 121-220) (Cy3)

Produktnummer ABIN1408245

Dieses Anti-FGFBP2-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von FGFBP2 in IF (cc) und IF (p). Geeignet für Human.

Kurzübersicht für FGFBP2 Antikörper (AA 121-220) (Cy3) (ABIN1408245)

Target: FGFBP2 (Fibroblast Growth Factor Binding Protein 2 (FGFBP2))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser FGFBP2 Antikörper ist konjugiert mit Cy3

Applikation: Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Produktdetails anti-FGFBP2 Antikörper (Cy3)

Bindungsspezifität: AA 121-220

Kreuzreaktivität: Human

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human FGFBP2/KSP37

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Haltbarkeit: 12 months

Details zu FGFBP2

Target: FGFBP2 (Fibroblast Growth Factor Binding Protein 2 (FGFBP2))

Andere Bezeichnung: FGFBP2/KSP37

Hintergrund:

Synonyms: FGF-binding protein 2, FGF-BP2, FGFBP-2, FGFBP2, FGFP2_HUMAN, Fibroblast growth factor-binding protein 2, HBp17-related protein, HBp17-RP, Ksp37, 37 kDa killer-specic secretory protein.

Background: KSP37 is a 223 amino acid protein that is secreted into the extracellular space and belongs to the fibroblast growth factor-binding protein family. Expressed in serum, as well as in cytotoxic T lymphocytes and peripheral leukocytes, KSP37 is thought to be involved in lymphocyte-mediated immunity, possibly playing a role in the development of asthma. The gene encoding KSP37 maps to human chromosome 4, which encodes nearly 6 % of the human genome and has the largest gene deserts (regions of the genome with no protein encoding genes) of all of the human chromosomes. Defects in some of the genes located on chromosome 4 are associated with Huntington's disease, Ellis-van Creveld syndrome, methylmalonic acidemia and polycystic kidney disease.